Rockefeller Capital Management L.P. Raises Holdings in Pediatrix Medical Group, Inc. $MD

Rockefeller Capital Management L.P. raised its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 814.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 594,351 shares of the company’s stock after buying an additional 529,367 shares during the quarter. Rockefeller Capital Management L.P. owned about 0.72% of Pediatrix Medical Group worth $12,713,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. Global Retirement Partners LLC boosted its stake in shares of Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after acquiring an additional 1,365 shares during the last quarter. Transamerica Financial Advisors LLC acquired a new position in Pediatrix Medical Group in the 4th quarter valued at about $30,000. Eurizon Capital SGR S.p.A. acquired a new position in Pediatrix Medical Group in the 4th quarter valued at about $33,000. Blue Trust Inc. purchased a new position in Pediatrix Medical Group in the 4th quarter valued at about $37,000. Finally, TD Private Client Wealth LLC purchased a new position in Pediatrix Medical Group in the 4th quarter valued at about $39,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Up 1.6%

Shares of MD opened at $24.24 on Thursday. Pediatrix Medical Group, Inc. has a twelve month low of $11.84 and a twelve month high of $24.99. The firm has a market capitalization of $1.99 billion, a P/E ratio of 11.77 and a beta of 0.69. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. The stock’s fifty day simple moving average is $22.81 and its 200 day simple moving average is $21.71.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The firm had revenue of $476.20 million during the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.33 earnings per share. On average, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 2.1 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on MD shares. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a report on Monday, April 13th. Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Friday, March 27th. UBS Group boosted their price target on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Finally, Jefferies Financial Group restated a “buy” rating and set a $27.00 price objective on shares of Pediatrix Medical Group in a report on Monday, April 20th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $22.50.

Insider Buying and Selling

In other Pediatrix Medical Group news, Director Shirley A. Weis sold 36,028 shares of Pediatrix Medical Group stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 1.80% of the company’s stock.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.